Dr Joel R Temple, MD | |
9 E Loockerman St, Suite 303, Dover, DE 19901-8306 | |
(302) 678-1343 | |
(302) 678-1344 |
Full Name | Dr Joel R Temple |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 9 E Loockerman St, Dover, Delaware |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1891793352 | NPI | - | NPPES |
0000021401 | Medicaid | DE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207KA0200X | Allergy & Immunology - Allergy | C1 0000597 (Delaware) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Joel R Temple, MD 9 E Loockerman St, Suite 303, Dover, DE 19901-8306 Ph: (302) 678-1343 | Dr Joel R Temple, MD 9 E Loockerman St, Suite 303, Dover, DE 19901-8306 Ph: (302) 678-1343 |
News Archive
The National Institutes of Natural Sciences, National Institute for Fusion Science and The University of Tokyo Graduate School of Frontier Sciences Department of Advanced Materials Science research group have developed an electron density diagnostic method for atmospheric pressure low-temperature plasma that is anticipated to be applicable for the fields of environmental protection and of medicine and biology.
Research funded by the Wellcome Trust has provided a number of promising new drug targets for Huntington's disease, a neurodegenerative disease.
There are many false beliefs and myths about the role of oxidants and antioxidants in the human body. Traditionally, oxidants are presented as harmful and antioxidants as health-promoting. However, scientists have known for many years that endogenous oxidants are essential chemical messengers that help keep up the functions of the organism.
Researchers from Japan have developed a new polysulfide donor: a chemical compound composed of chains of sulfur atoms that can artificially increase reactive sulfur species (chemically reactive molecules containing sulfur) in cells and tissues.
Illumina, Inc. and Bio-Rad Laboratories, Inc. today announced the launch of the Illumina® Bio-Rad® Single-Cell Sequencing Solution at the J.P. Morgan Healthcare Conference. The comprehensive solution is the first next-generation sequencing (NGS) workflow for single-cell analysis, providing researchers the ability to investigate the coordinated contribution of individual cells in tissue function, disease progression, and therapeutic response.
› Verified 3 days ago
Shankar Lakhani, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 200 Banning St Ste 280, Dover, DE 19904 Phone: 302-734-4434 | |
Dr. William Edwin Hermance, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 18 Old Rudnick Lane, Dover, DE 19901 Phone: 302-674-3935 Fax: 302-674-8518 |